Tarsus Pharmaceuticals, Inc. (TARS) on GreekSoup https://greeksoup.ai/stocks/us/tars/ Every dated entry in the public record on Tarsus Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Tarsus Pharmaceuticals, Inc.: short interest 5,731,409 shares at the 15 October 2026 settlement, 5.71 days to coverhttps://greeksoup.ai/stocks/us/tars/short-interest/us:TARS:short-interest:2026-10-15:4969c7ad56Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed 8-K/A: 8-k/ahttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-10-13:228af4a43dTue, 13 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed S-3ASR: s-3asrhttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-10-13:290a46c7c6Tue, 13 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed S-3ASR: s-3asrhttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-10-13:1e35c99650Tue, 13 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: short interest 6,070,928 shares at the 30 September 2026 settlement, 8.29 days to coverhttps://greeksoup.ai/stocks/us/tars/short-interest/us:TARS:short-interest:2026-09-30:a6388db977Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Link William J Phd (Director) sold 11,675 shares (under a trading plan set in advance) at $78.33 on 15 September 2026, $914,503https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-17:f97101704cThu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Link William J Phd (Director) sold 759 shares (under a trading plan set in advance) at $79.00 on 15 September 2026, $59,961https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-17:528d6564a1Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Link William J Phd (Director) sold 66 shares (under a trading plan set in advance) at $80.01 on 15 September 2026, $5,281https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-17:7f0834a489Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, WILLIAM J LINK plans to sell 12,500 shares worth $979,745 around 15 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-15:7390106f9cTue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: short interest 6,127,884 shares at the 15 September 2026 settlement, 6.64 days to coverhttps://greeksoup.ai/stocks/us/tars/short-interest/us:TARS:short-interest:2026-09-15:de0193a5c1Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed 8-K: acquisition or disposition completed, other eventshttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-09-10:87991feed7Thu, 10 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Azamian Bobak R. (President/CEO and Board Chair), by the Bobak Azamian Living Trust established April 16, 2018, sold 7,100 shares (under a trading plan set in advance) at $90.27 on 4 September 2026, $640,917https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:df75a66e97Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Azamian Bobak R. (President/CEO and Board Chair), by the Bobak Azamian Living Trust established April 16, 2018, sold 2,900 shares (under a trading plan set in advance) at $91.27 on 4 September 2026, $264,683https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:8e659dfbbbWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer) sold 5,387 shares (under a trading plan set in advance) at $85.00 on 4 September 2026, $457,895https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:cb16488b0eWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer) sold 5,386 shares (under a trading plan set in advance) at $90.00 on 4 September 2026, $484,740https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:2cdf10bb29Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer), by Spouse's Roth IRA, sold 1,590 shares (under a trading plan set in advance) at $85.00 on 4 September 2026, $135,150https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:8b3509833aWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer), by Spouse's Roth IRA, sold 1,590 shares (under a trading plan set in advance) at $90.00 on 4 September 2026, $143,100https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:6f4117240fWed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Neervannan Seshadri (Chief Operating Officer) sold 4,564 shares (under a trading plan set in advance) at $85.00 on 4 September 2026, $387,940https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-09:881ae39b87Wed, 09 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Lin Elizabeth Yeu plans to sell 3,180 shares worth $278,250 around 4 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-04:7c4b7486a9Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Neervannan Seshadri plans to sell 4,564 shares worth $387,940 around 4 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-04:e1e50b3de1Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, BOBAK AZAMIAN plans to sell 10,000 shares worth $905,587 around 4 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-04:e1b80b234fFri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Lin Elizabeth Yeu plans to sell 10,773 shares worth $942,635 around 4 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-04:27ae578360Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Azamian Bobak R. (President/CEO and Board Chair), by the Bobak Azamian Living Trust established April 16, 2018, sold 10,000 shares (under a trading plan set in advance) at $80.06 on 2 September 2026, $800,600https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-03:6b6efbd080Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer) sold 5,387 shares (under a trading plan set in advance) at $80.00 on 2 September 2026, $430,960https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-03:6328c1eec9Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer), by Spouse's Roth IRA, sold 1,590 shares (under a trading plan set in advance) at $80.00 on 2 September 2026, $127,200https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-03:e93c0b2acfThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Lin Elizabeth Yeu (Chief Medical Officer) sold 4,601 shares (under a trading plan set in advance) at $73.86 on 1 September 2026, $339,830https://greeksoup.ai/stocks/us/tars/insiders/us:TARS:insider:2026-09-03:2a19ca6dfcThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Lin Elizabeth Yeu plans to sell 1,590 shares worth $127,200 around 2 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-02:6961e1f51aWed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Lin Elizabeth Yeu plans to sell 5,387 shares worth $430,960 around 2 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-02:77561ec54eWed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Mottiwala Aziz plans to sell 8,000 shares worth $654,373 around 2 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-02:58b51f04b6Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, BOBAK AZAMIAN plans to sell 10,000 shares worth $800,569 around 2 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-02:37beeee6d4Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Lin Elizabeth Yeu plans to sell 4,601 shares worth $339,830 around 1 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-01:68c6bbe7e5Tue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Mottiwala Aziz plans to sell 77,698 shares worth $5.7 million around 1 September 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-09-01:c096026d8dTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: short interest 6,011,550 shares at the 31 August 2026 settlement, 9.80 days to coverhttps://greeksoup.ai/stocks/us/tars/short-interest/us:TARS:short-interest:2026-08-31:7fc6ad57dfMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Mottiwala Aziz plans to sell 81,332 shares worth $5.8 million around 25 August 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-08-25:12ffc5f2f5Tue, 25 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Form 144, Mottiwala Aziz plans to sell 53,043 shares worth $3.8 million around 19 August 2026https://greeksoup.ai/stocks/us/tars/planned-sales/us:TARS:planned-sale:2026-08-19:6e039802d9Wed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: short interest 5,997,475 shares at the 14 August 2026 settlement, 7.49 days to coverhttps://greeksoup.ai/stocks/us/tars/short-interest/us:TARS:short-interest:2026-08-14:9ae5c2812aFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: Schedule 13G/A filed by JANUS HENDERSON GROUP Ltd., 6.5% of the classhttps://greeksoup.ai/stocks/us/tars/holders/us:TARS:schedule-13:2026-08-13:bdbef0e9cdThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. Q2 FY2026 results: revenue $174 million, net income -$19 millionhttps://greeksoup.ai/stocks/us/tars/results/fy2026-q2/us:TARS:result:2026-08-06:311c34c5daThu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-08-06:be60000897Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-08-06:99bcb6f510Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed 8-K: material agreement, unregistered sale of equity, other eventshttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-08-06:4d61379583Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc. filed 8-K: material agreement, unregistered sale of equity, other eventshttps://greeksoup.ai/stocks/us/tars/filings/us:TARS:filing:2026-08-06:552f939429Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tarsus Pharmaceuticals, Inc.: short interest 6,016,830 shares at the 31 July 2026 settlement, 6.58 days to coverhttps://greeksoup.ai/stocks/us/tars/short-interest/us:TARS:short-interest:2026-07-31:d92bb334ffFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>